Classification and mitigation of negative injection experiences with biologic medications

Area of Science:

• Dermatology
• Pharmacology
• Immunology

Background:

• Injection site reactions (ISRs) are common with biologic medications, manifesting as pain and irritation.
• Current classification systems for ISRs are often impractical or insufficient for clinical use.
• Negative injection experiences (NIEs) are a significant barrier to patient adherence with biologic therapies.

Purpose of the Study:

• To propose a novel, intuitive clinical classification system for negative injection experiences (NIEs) associated with biologic medications.
• To provide practical recommendations for mitigating ISRs and improving patient adherence.
• To enhance understanding and management of ISRs for dermatologists and patients.

Main Methods:

• A review of existing literature on injection site reactions and biologic medications.
• Development of a new classification system categorizing NIEs into physical, irritant, and allergic types.
• Formulation of clinical recommendations based on the proposed classification.

Main Results:

• NIEs were categorized into three distinct types: physical (needle/process-related), irritant (solution-related), and allergic (immediate/delayed).
• The proposed classification offers a more intuitive framework compared to previous systems.
• Recommendations for mitigation strategies were developed for each category of NIE.

Conclusions:

• A clear classification of NIEs is crucial for effective management of ISRs.
• The proposed classification system can aid clinicians in diagnosing and managing ISRs.
• Addressing NIEs through improved classification and mitigation strategies may enhance patient adherence to biologic therapies.